Sergliflozin A
Sergliflozin A is a potent and selective SGLT2 inhibitor used in diabetes research. It demonstrates a dose-dependent induction of diabetic phenotypes while effectively lowering blood glucose levels in experimental models. This compound is a valuable tool for in vitro and in vivo studies of glucose metabolism and SGLT2 function.
Product Specifications
CAS Number
360775-96-8
Product Name Alternative
SGLT2
Field of Research
Pharmacology & Drug Discovery
Purity
99.43% (May vary between batches)
Solubility
DMSO:38.46 mg/mL (102.18 mM)
Smiles
O (C1=C (CC2=CC=C (OC) C=C2) C=CC=C1) [C@@H]3O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]3O
Molecular Formula
C20H24O7
Molecular Weight
376.4
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-D232070-5MG 5 mg
3'-Deoxyadenosine 5’-Triphosphate Triethylamine Salt
Sign In for Pricing
View Details 
BNC041686-100 1x 100 µL
VEGF (Vascular Endothelial Growth Factor) (VG1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details